Alembic Pharma international formulations grew 10pc to Rs 646 crore in Q2 Medical Dialogues Bureau28 Oct 2019 9:30 AM ISTAlembic said its international formulations grew 10 per cent to Rs 646 crore in the quarter under review and 17 per cent to Rs 1,099 crore in the...
Foamix Pharma wins USFDA nod for Amzeeq, topical minocycline treatment for acne Medical Dialogues Bureau28 Oct 2019 9:15 AM IST“The USFDA approval of AMZEEQ ((minocycline) topical foam, is a milestone moment in dermatology and the most significant advancement with minocycline...
Alexion Pharma to acquire clinical-stage biopharmaceutical firm Achillion Medical Dialogues Bureau28 Oct 2019 9:00 AM ISTNew Delhi: Alexion Pharmaceuticals, Inc. and Achillion Pharmaceuticals, Inc. recently announced that they have entered into a definitive agreement...
CDSCO committee tells Roche to submit Phase III clinical trial data of blood cancer combo drug Farhat Nasim27 Oct 2019 11:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO), recently recommended drugmaker,...
Jubilant Life gets ANDA final nod for Clomipramine Hydrochloride Capsules to treat OCD Medical Dialogues Bureau27 Oct 2019 10:00 AM ISTNew Delhi: Jubilant Life Sciences Ltd recently announced that Jubilant Pharma Limited, a material wholly-owned subsidiary of the Company, through one...
Novartis boosts 2019 forecasts as Cosentyx, Zolgensma shine Medical Dialogues Bureau27 Oct 2019 9:45 AM ISTZolgensma, the $2.1 million-per-patient treatment for spinal muscular atrophy, posted $160 million in sales. Novartis now anticipated approval in...
Strides Pharma reports revenue of Rs 718 crore for Q2 Medical Dialogues Bureau27 Oct 2019 9:32 AM ISTEBITDA margins stood at 21 per cent, up by 300 basis point quarter-on-quarter and 1,170 bps year-on-year. EBITDA margin expansion was led by good...
Alexion Ultomiris gets USFDA approval for treating another rare blood disease Medical Dialogues Bureau27 Oct 2019 9:15 AM ISTThe treatment, Ultomiris, has already been approved in the United States, Japan and the European Union to treat adults with a blood disorder called...
Biogen in consultation with USFDA plans regulatory filing for AD drug Aducanumab Medical Dialogues Bureau27 Oct 2019 9:00 AM ISTNew Delhi: Biogen and Eisai, Co., Ltd. (Tokyo, Japan) recently announced that, after consulting with the U.S. Food and Drug Administration (FDA),...
Dr Reddys gets CDSCO Committee recommendation for approval for additional indications of Desosumab Farhat Nasim26 Oct 2019 2:38 PM ISTRecently, the Hyderabad-based Dr Reddy's Labs presented its proposal before the CDSCO Committee for an additional indication for Denosumab 120...
Shilpa Medicare Telangana facility gets EIR from USFDA Medical Dialogues Bureau26 Oct 2019 11:46 AM IST"The USFDA has concluded that the inspection classification of Jadcherla facility was "voluntary action indicated". This facility is in an acceptable...
Aurobindo Pharma wins USFDA nod for generic version of Mucinex Tablets Medical Dialogues Bureau26 Oct 2019 10:00 AM ISTGuaifenesin extended-release tablets are the generic version of RB Health (US) LLC's Mucinex tablets, Aurobindo Pharma said.New Delhi: Drug firm...
